Our patented photonics and Artificial Intelligence system identifies unique features of various gold-standard biomarkers, capturing their signature on a cloud-based library.
Enabling a world where all biomarkers have a fingerprint.
Leveraging machine learning to drastically reduce the cost and time of drug discovery.
A new era of personalized medicine enabled by AI-based screening tools
Our artificial intelligence algorithms combined by photonics-based signals enable accurate optical fingerprints of various neuro-degenerative diseases.
Powered by a digital library of non-invasive digital library of biomarkers fingerprints, and enabling a future of portable, easily assessable screening tools.